Gensight Biologics SA

12/01/2021 | Press release | Distributed by Public on 12/01/2021 00:30

GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ® Vector DNA in Contralateral Eyes After Unilateral Injection

01 December 2021
  • Press releases
  • Study demonstrates contralateral transfer of LUMEVOQ® after unilateral injection
  • Results suggest mechanistic explanation for bilateral improvement of visual function among ND4-LHON patients unilaterally treated with LUMEVOQ®